CC
GSK icon

Columbia Capital’s GSK GSK Stock Holding History

Columbia Capital’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-2,206
Closed -$148K – 52
2014
Q2 		$148K Buy
2,206
+32
+1% +$2.17K 0.12% 66
2014
Q1 		$147K Buy
2,174
+25
+1% +$1.69K 0.11% 77
2013
Q4 		$144K Buy
2,149
+23
+1% +$1.49K 0.13% 61
2013
Q3 		$134K Sell
2,126
-59
-3% -$3.8K 0.12% 60
2013
Q2 		$136K Buy
+2,185
New +$139K 0.14% 55

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Columbia Capital's GSK Position: Q3 2014 in Review

Columbia Capital sold out of GSK (GSK) in Q3 2014, closing a stake of 2,206 shares — an estimated $148K sold.

Columbia Capital first reported a position in GSK in Q2 2013 and held it in 5 quarters. The position peaked at $148K in Q2 2014. 701 funds tracked by Wall St. Rank hold GSK as of Q3 2014.

  • Columbia Capital reported no remaining GSK position as of Q3 2014 after selling out during the quarter.
  • Columbia Capital sold 2,206 GSK shares in Q3 2014, an estimated $148K.
  • Columbia Capital first reported a position in GSK in Q2 2013 and held it in 5 quarters.
  • Columbia Capital's GSK position peaked at $148K in Q2 2014.
  • 701 funds tracked by Wall St. Rank held GSK as of Q3 2014.

Based on Columbia Capital's 13F filing for Q3 2014, filed 16 Oct 2014.